Regular Paper
Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation

https://doi.org/10.1016/S0168-8278(94)80107-XGet rights and content

We investigated the role of the donor liver in the origin of platelet disorders and hemostatic defects in liver transplantation. Eighteen pigs received an orthotopic or a heterotopic, auxiliary liver graft. Liver biopsies were taken for electron microscopic studies 5–10 min after reperfusion in nine animals. Blood samples were taken from the first hepatic outflow and from the systemic circulation before and 5 min after graft recirculation. Electron microscopy did not show any evidence of microthrombi or platelet aggregation in the graft, either after orthotopic liver transplantation or after heterotopic liver transplantation. Most blood platelets, which were lying free in the sinusoids, showed cell processes and many seemed to have lost their granulae, suggesting a degree of platelet activation. There were also signs of phagocytosis of platelets by the Kupffer cells. In the hepatic outflow, platelet count was significantly lower (p<0.05) and fibrinolytic activity significantly higher (p<0.01), than systemic post-reperfusion values. There were no important changes in the coagulation parameters. No significant changes were found between the effects on hemostasis of orthotopic and auxiliary graft reperfusion. In the second part of the study evidence for platelet activation was found after graft reperfusion in human liver transplantation. Plasma levels of platelet factor-4 and β-thromboglobulin increased significantly after graft reperfusion. These studies suggest that platelet disorders and increased fibrinolytic activity are the major components of the hemostatic defect after graft recirculation in liver transplantation. Sequestration of platelets in the graft is probably due to the accumulation of (activated and degranulated) platelets in the sinusoids and phagocytosis by Kupffer cells.

References (37)

  • LewisJH et al.

    Blood use in liver transplantation

    Transfusion

    (1987)
  • KangYG et al.

    Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation

    Anesth Analg

    (1985)
  • GrothCG et al.

    Coagulation during and after orthotopic transplantation of the human liver

    Arch Surg

    (1969)
  • HutchisonDE et al.

    Platelet changes following clinical and experimental hepatic homotransplantation

    Arch Surg

    (1968)
  • SchalmSW et al.

    Orthotopic liver transplantation: an experimental study on mechanisms of hemorrhagic diathesis and thrombosis

    Surgery

    (1975)
  • GrothCG

    Changes in coagulation

  • PorteRJ et al.

    Systemic effects of tissue plasminogen activator associated fibrinolysis and the relation with thrombin generation in orthotopic liver transplantation

    Transplantation

    (1989)
  • PechetL et al.

    Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation

    J Lab Clin Med

    (1969)
  • Cited by (59)

    • Coagulation, hemostasis, and transfusion during liver transplantation

      2020, Best Practice and Research: Clinical Anaesthesiology
      Citation Excerpt :

      More portal hypertension will possibly cause more blood loss especially during the dissection phase. In addition to the known role of platelets in primary hemostasis, platelets play an important role in regulating inflammation, angiogenesis, tissue repair/regeneration, and ischemia and reperfusion injury [32–35], all of which are important factors during liver transplantation. Although many patients with end-stage liver disease are thrombocytopenic, platelet function is usually adequate due to increased levels of vWF and decreased levels of ADAMTS-13 [36].

    • The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction

      2015, Cytokine and Growth Factor Reviews
      Citation Excerpt :

      Roles for CXCL4 and CXCL4L1 in various liver diseases have been described previously. For example, in some studies, graft liver biopsy samples from patients with liver allograft dysfunction showed thrombotic occlusions of the microcirculation with abnormal CXCL4 expression [11,66]. However, the mechanism of CXCL4 and CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction remains unknown.

    View all citing articles on Scopus
    View full text